| pubmed-article:15450037 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15450037 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
| pubmed-article:15450037 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
| pubmed-article:15450037 | lifeskim:mentions | umls-concept:C0085504 | lld:lifeskim |
| pubmed-article:15450037 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:15450037 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:15450037 | pubmed:dateCreated | 2004-9-28 | lld:pubmed |
| pubmed-article:15450037 | pubmed:abstractText | To assess the prevalence of Chlamydia pneumoniae (CP) seropositivity and test the hypothesis that CP infection (CPI) is associated with cardiovascular (CV) risk factors and levels of inflammatory biomarkers. | lld:pubmed |
| pubmed-article:15450037 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15450037 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15450037 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15450037 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15450037 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15450037 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15450037 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:15450037 | pubmed:issn | 0002-8614 | lld:pubmed |
| pubmed-article:15450037 | pubmed:author | pubmed-author:OlivieriFabio... | lld:pubmed |
| pubmed-article:15450037 | pubmed:author | pubmed-author:GabbutiAndrea... | lld:pubmed |
| pubmed-article:15450037 | pubmed:author | pubmed-author:FerrucciLuigi... | lld:pubmed |
| pubmed-article:15450037 | pubmed:author | pubmed-author:MeacciFrances... | lld:pubmed |
| pubmed-article:15450037 | pubmed:author | pubmed-author:PeduzziCecili... | lld:pubmed |
| pubmed-article:15450037 | pubmed:author | pubmed-author:CorsiAnna... | lld:pubmed |
| pubmed-article:15450037 | pubmed:author | pubmed-author:MazzottaFranc... | lld:pubmed |
| pubmed-article:15450037 | pubmed:author | pubmed-author:LauretaniFulv... | lld:pubmed |
| pubmed-article:15450037 | pubmed:author | pubmed-author:BlancPierluig... | lld:pubmed |
| pubmed-article:15450037 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15450037 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:15450037 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15450037 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15450037 | pubmed:pagination | 1626-31 | lld:pubmed |
| pubmed-article:15450037 | pubmed:dateRevised | 2008-3-10 | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:meshHeading | pubmed-meshheading:15450037... | lld:pubmed |
| pubmed-article:15450037 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15450037 | pubmed:articleTitle | Chlamydia pneumoniae seropositivity and cardiovascular risk factors: The InCHIANTI Study. | lld:pubmed |
| pubmed-article:15450037 | pubmed:affiliation | Infectious Diseases Section, Hospital SS Annunziata, Florence, Italy. | lld:pubmed |
| pubmed-article:15450037 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15450037 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15450037 | lld:pubmed |
